InvisiShield Technologies
PrivateCompany Overview
InvisiShield Technologies is a biotechnology company that develops intranasal preventive sprays designed to neutralize respiratory viruses such as SARS-CoV-2, influenza, and RSV.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
intranasal sprayrespiratory virus preventionantibody engineeringnasal vaccinebiotechmucoadhesive technologycapture and killvariant-proof protectiondrug discoverymucosal immunitynasal spray vaccinebiopharmaceuticalpreclinical research
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InvisiShield Technologies Comparables
Compare InvisiShield Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthLinks Bio | 85% | |
| Leyden Labs | 79% | |
| ENA Respiratory | 78% | |
InvisiShield Technologies Funding Rounds
Historical fundraising activity
InvisiShield Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InvisiShield Technologies's valuation, stock price, and market status.